FDA Inspection
Glaxo Operations UK LimitedGlaxo Operations UK Limited – FDA Inspection, Sep 6, 2019
Record Details
This FDA Inspection record concerns Glaxo Operations UK Limited, with an inspection on September 6, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 93a229ee-cd04-416d-8be7-71aad893fb17
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1102175
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.113(a)Procedures for non-sterile drug products
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Glaxo Operations UK Limited
7| Date | Classification | Office | Project area |
|---|---|---|---|
| December 6, 2024 | Not classified | Office of Inspections and Investigations | |
| January 25, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 10, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 12, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 25, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Glaxo Operations UK Limited
- FDA Inspection 1267917 - 2024-12-06
- FDA Inspection 1099616 - 2019-01-25
- FDA Inspection 935343 - 2015-07-10
- FDA Inspection 898406 - 2014-09-12
- FDA Inspection 827578 - 2013-04-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.